Ueberberg, Sandra <br/><br/>
Histological changes in endocrine and exocrine pancreatic tissue from patients exposed to incretin-based therapies.  [electronic resource] 

 -  Diabetes, obesity & metabolism  12 2016 
 - 1253-1262 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1463-1326 
<br/><br/><label>Standard No.: </label>10.1111/dom.12766  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acinar Cells--pathology<br/>Adamantane--analogs & derivatives<br/>Adenocarcinoma--surgery<br/>Adult<br/>Aged<br/>Carcinoma in Situ--epidemiology<br/>Case-Control Studies<br/>Cystadenoma--surgery<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Digestive System Surgical Procedures<br/>Dipeptides--therapeutic use<br/>Exenatide<br/>Female<br/>Glucagon--metabolism<br/>Glucagon-Secreting Cells--metabolism<br/>Humans<br/>Incretins--therapeutic use<br/>Insulin--metabolism<br/>Insulin-Secreting Cells--metabolism<br/>Islets of Langerhans--metabolism<br/>Male<br/>Middle Aged<br/>Neuroendocrine Tumors--surgery<br/>Nitriles--therapeutic use<br/>Organ Size<br/>Pancreas--surgery<br/>Pancreas, Exocrine--pathology<br/>Pancreatic Neoplasms--epidemiology<br/>Pancreatitis, Chronic--surgery<br/>Peptides--therapeutic use<br/>Pyrrolidines--therapeutic use<br/>Sitagliptin Phosphate--therapeutic use<br/>Tissue Donors<br/>Venoms--therapeutic use<br/>Vildagliptin